Could a vaccine treat cancer? Texas Oncology testing mRNA Moderna shot for melanoma
Texas Oncology is testing an mRNA melanoma vaccine in a stage 3 trial, aiming to improve future melanoma treatment outcomes.
Texas Oncology has enrolled patients in an innovative stage 3 clinical trial testing an mRNA vaccine for melanoma treatment. Jeff Yorio, M.D., Texas Oncology-Austin Central, shared how the melanoma vaccine is created, what results are expected and what the trial could mean for the future of melanoma treatment.
Click here to read the full story.
Click here to read the full story.